Hemorrhagic complications of thoracentesis and small-bore chest tube placement in patients taking clopidogrel.

RATIONALE Clopidogrel is a commonly used antiplatelet medication. The risk of local hemorrhage associated with use of this drug during routine thoracentesis or small-bore chest tube placement is not well established. OBJECTIVES We conducted a prospective cohort study to assess the risk of hemothorax in patients taking clopidogrel while undergoing either pleural procedure. METHODS Twenty-five consecutive adult patients who were taking clopidogrel at the time they were offered thoracentesis or small-bore (14 Fr) chest tube placement consented to continue taking the drug through their procedure. A control group consisted of 50 patients undergoing these pleural procedures who were not taking clopidogrel at the time they consented to undergo either procedure. All of the pleural procedures were performed under ultrasound guidance by an interventional pulmonologist or a fellow under direct faculty supervision. Hospitalized patients were screened for hemothorax by observing for a post-procedure drop in blood hemoglobin content of 2 g/dl or reaccumulation of their pleural effusion within 24 hours of the procedure. Outpatients were called within 2 weeks after their procedure to determine whether they had any symptoms suggestive of hemothorax. MEASUREMENTS AND MAIN RESULTS There was one case of hemothorax after thoracentesis in the clopidogrel group versus none in the control group. The one patient with hemothorax required transfusion with 2 units of packed red blood cells and small-bore chest tube placement, and clopidogrel was withheld. There were no other clinically apparent complications of either procedure. CONCLUSIONS Considered in combination with other small previously published studies, this single-center, nonrandomized, controlled prospective cohort study suggests that the rate of clinically consequential hemorrhage after ultrasound-guided thoracentesis or chest tube placement in patients taking clopidogrel is sufficiently low to warrant a large, randomized clinical trial designed to determine the safety of performing these procedures without interrupting clopidogrel therapy.

[1]  T. Paul.  Erwachsene mit einem angeborenen Herzfehler , 2013 .

[2]  T. Murphy,et al.  The safety of thoracentesis in patients with uncorrected bleeding risk. , 2013, Annals of the American Thoracic Society.

[3]  T. Atwell,et al.  Safety of ultrasound-guided thoracentesis in patients with abnormal preprocedural coagulation parameters. , 2013, Chest.

[4]  M. Wahidi,et al.  Straightening out chest tubes: what size, what type, and when. , 2013, Clinics in chest medicine.

[5]  A. Bollmann,et al.  Influence of oral antiplatelet therapy on hemorrhagic complications of pacemaker implantation , 2013, Clinical Research in Cardiology.

[6]  S. Lanes,et al.  Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis. , 2013, Chest.

[7]  M. Pratter,et al.  Safety of Ultrasound-guided Small-Bore Chest Tube Insertion in Patients on Clopidogrel , 2013, Journal of bronchology & interventional pulmonology.

[8]  N. Altorki,et al.  Management and Outcomes of Patients on Preoperative Plavix (Clopidogrel) Undergoing General Thoracic Surgery , 2012, Thoracic and Cardiovascular Surgeon.

[9]  T. Bartter,et al.  Is chest tube insertion with ultrasound guidance safe in patients using clopidogrel? , 2012, Respirology.

[10]  R. Bechara,et al.  Effect of Routine Clopidogrel Use on Bleeding Complications After Ultrasound-guided Thoracentesis , 2012, Journal of bronchology & interventional pulmonology.

[11]  C. Claussen,et al.  Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trial , 2012, European Radiology.

[12]  F. Ernst,et al.  Ultrasonography guidance reduces complications and costs associated with thoracentesis procedures , 2012, Journal of clinical ultrasound : JCU.

[13]  D. Fielding,et al.  Thoracic Ultrasound Demonstrates Variable Location of the Intercostal Artery , 2012, Respiration.

[14]  M. Berry,et al.  Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection. , 2011, The Annals of thoracic surgery.

[15]  Maitray D. Patel,et al.  Abnormal preprocedural international normalized ratio and platelet counts are not associated with increased bleeding complications after ultrasound-guided thoracentesis. , 2011, AJR. American journal of roentgenology.

[16]  N. Cruden,et al.  Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting. , 2011, American heart journal.

[17]  R. Cerfolio,et al.  General thoracic surgery is safe in patients taking clopidogrel (Plavix). , 2010, The Journal of thoracic and cardiovascular surgery.

[18]  M. Yacovone,et al.  Intercostal artery laceration following thoracentesis. , 2010, Respiratory care.

[19]  Chia-Hung Chen,et al.  Ultrasound-guided pigtail catheters for drainage of various pleural diseases. , 2010, The American journal of emergency medicine.

[20]  D. Haines,et al.  Risk of Hematoma Complications After Device Implant in the Clopidogrel Era , 2010, Circulation. Arrhythmia and electrophysiology.

[21]  F. Gleeson,et al.  Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010 , 2010, Thorax.

[22]  V. Kaul,et al.  Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapy. , 2010, Gastrointestinal endoscopy.

[23]  K. Buth,et al.  Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. , 2010, The Annals of thoracic surgery.

[24]  M. A. Soliman Hamad,et al.  Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[26]  G. Vanzetto,et al.  Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry. , 2007, Journal of the American College of Cardiology.

[27]  M. Wahidi,et al.  Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. , 2006, Chest.

[28]  K. Kent,et al.  Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents , 2006, Circulation.

[29]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[30]  A. Skene,et al.  Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. , 2005, The New England journal of medicine.

[31]  Fernando Alfonso,et al.  Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. , 2005, Journal of the American College of Cardiology.

[32]  P. Mayo,et al.  Safety of ultrasound-guided thoracentesis in patients receiving mechanical ventilation. , 2004, Chest.

[33]  R. Light,et al.  Ultrasound-guided thoracentesis: is it a safer method? , 2003, Chest.

[34]  A. Diacon,et al.  Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. , 2003, Chest.

[35]  Eric J Topol,et al.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[36]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[37]  P. McVay,et al.  Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities , 1991, Transfusion.

[38]  V. Raptopoulos,et al.  Complications associated with thoracentesis. A prospective, randomized study comparing three different methods. , 1990, Archives of internal medicine.

[39]  L. Gold,et al.  Complications associated with thoracocentesis. , 1986, Chest.

[40]  K. O’Regan,et al.  Demonstration of the course of the posterior intercostal artery on CT angiography: relevance to interventional radiology procedures in the chest. , 2012, Diagnostic and interventional radiology.

[41]  S. Shankar,et al.  Image-guided percutaneous drainage of thoracic empyema: Can sonography predict the outcome? , 2000, European Radiology.

[42]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .